ChimeriVax-hepatitis C virus (Acambis)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameChimeriVax-hepatitis C virus (Acambis)
Drug Alias Namehepatitis C virus vaccine (Peptide Therapeutics Group/Aventis Pasteur)hepatitis C virus vaccine (Acambis/Aventis Pasteur)ChimeriVax (Peptide Therapeutics/Aventis Pasteur)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSaint Louis University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcambisSanofi Pasteur Sa
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A